# SLOS: The Effect of Simvastatin in Patients Receiving Cholesterol Supplementation

> **NCT01434745** · NA · TERMINATED · sponsor: **Oregon Health and Science University** · enrollment: 1 (actual)

## Conditions studied

- Smith-Lemli-Opitz Syndrome

## Interventions

- **DRUG:** Simvastatin
- **DIETARY_SUPPLEMENT:** Lactose

## Key facts

- **NCT ID:** NCT01434745
- **Lead sponsor:** Oregon Health and Science University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2011-09
- **Primary completion:** 2014-10
- **Final completion:** 2014-10
- **Target enrollment:** 1 (ACTUAL)
- **Why stopped:** poor enrollment (only one subject enrolled)
- **Last updated:** 2019-10-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01434745

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01434745, "SLOS: The Effect of Simvastatin in Patients Receiving Cholesterol Supplementation". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01434745. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*